Finco T.S., Justice-Healy G.E., Patel S.J., Hamilton V.E.

BMC Mol. Biol. 7:4-4(2006) GeneRIF 1997 · Mapped (10)
transcriptional regulation of the LAT gene including the discovery that the Ets transcription factor Elf-1 may play a central role in its expression GeneRIF 1997

Andrews P.G., Kennedy M.W., Popadiuk C.M., Kao K.R.

Mol. Cancer Res. 6:259-266(2008) GeneRIF 1997 · Mapped (7)
These results provide new evidence that Elf-1 is involved in transcriptional activation of hPygo2. GeneRIF 1997

Takahashi K., Hayashi N., Shimokawa T., Umehara N., Kaminogawa S., Ra C.

J. Biol. Chem. 283:15134-15141(2008) GeneRIF 1997 · Mapped (16)
Elf-1 in combination with Sp1 and GABP reduced FcRgamma promoter activity. GeneRIF 1997

Juang Y.T., Wang Y., Jiang G., Peng H.B., Ergin S., Finnell M., Magilavy A., Kyttaris V.C., Tsokos G.C.

J. Immunol. 181:3658-3664(2008) GeneRIF 1997 · Mapped (3)
aberrantly increased PP2A in lupus T cells dephosphorylates Elf-1 at Thr-231 resulting in limited expression and binding of the 98 kDa Elf-1 form to the CD3zeta and FcRgamma promoters. GeneRIF 1997

Yang D.X., Han Y.C., Liu L.Y., Yu N., Wang X., Shi Y.

Ai Zheng 28:762-767(2009) GeneRIF 1997 · Mapped (10)
The expression levels of both Elf-1 and VEGF were significantly related with tumor differentiation lymphatic metastasis clinical stage and postoperative survival time in non-small cell lung cancer. GeneRIF 1997

Jin E., Liu J., Suehiro J., Yuan L., Okada Y., Nikolova-Krstevski V., Yano K., Janes L., Beeler D., Spokes K.C. et al.

Blood 114:5557-5566(2009) GeneRIF 1997 · Mapped (18)
Data show that VEGFR1 promoter binding sites for ELF-1 CREB and EGR-1/3 play a positive role in gene transcription in endothelial cells. GeneRIF 1997

Yang D.X., Li N.E., Ma Y., Han Y.C., Shi Y.

Chin J Cancer 29:396-402(2010) GeneRIF 1997 · Mapped (3)
The expression of Elf-1 and survivin in non-small cell lung cancer is related to differentiation lymphatic metastasis clinical stage and prognosis and both are positively correlated with microvessel density. GeneRIF 1997

Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R.

Mol. Med. 16:247-253(2010) GeneRIF 1997 · Mapped (10,283)
Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) GeneRIF 1997

Xiang P., Lo C., Argiropoulos B., Lai C.B., Rouhi A., Imren S., Jiang X., Mager D., Humphries R.K.

Exp. Hematol. 38:798-8, 2010:808.e1-2(2010) GeneRIF 1997 · Mapped (12)
ETS transcription factor ELF1 is an important positive regulator of MEIS1 expression GeneRIF 1997

Yang J., Yang W., Hirankarn N., Ye D.Q., Zhang Y., Pan H.F., Mok C.C., Chan T.M., Wong R.W., Mok M.Y. et al.

Hum. Mol. Genet. 20:601-607(2011) GeneRIF 1997 · Mapped (3)
Observational study and genome-wide association study of gene-disease association. (HuGE Navigator); through a genome-wide association in a Hong Kong Chinese cohort and replication in 2 other Asian populations identified association of ELF1 with systemic lupus erythematosus GeneRIF 1997

Gerloff A., Dittmer A., Oerlecke I., Holzhausen H.J., Dittmer J.

Oncol. Rep. 26:1121-1125(2011) GeneRIF 1997 · Mapped (3)
Data suggest that Elf-1 may modulate breast cancer progression to some extent without having an impact on survival of breast cancer patients. GeneRIF 1997

Sugi Y., Takahashi K., Nakano K., Hosono A., Kaminogawa S.

Biochem. Biophys. Res. Commun. 412:704-709(2011) GeneRIF 1997 · Mapped (10)
the results indicate that insufficient O-GlcNAc modification prevents Elf-1-mediated transcriptional repression and thereby upregulates Tollip gene expression in intestinal epithelial cells. GeneRIF 1997

Okada Y., Nobori H., Shimizu M., Watanabe M., Yonekura M., Nakai T., Kamikawa Y., Wakimura A., Funahashi N., Naruse H. et al.

PLoS ONE 6:e24837-e24837(2011) GeneRIF 1997 · Mapped (8)
Expression of FLI-1 ELF-1 and GABP activated the PF4 promoter in HepG2 cells. GeneRIF 1997